Pneumococcal virulence factors in community-acquired pneumonia.

Current Opinion in Pulmonary Medicine
Charles Feldman, Ronald Anderson

Abstract

This manuscript reviews the recent literature related to new developments in the understanding of existing and novel virulence factors of the pneumococcus that are of potential importance in the development of novel preventive and therapeutic strategies. The pneumococcal capsule and pneumolysin have long been recognized as being two of the most prominent virulence factors, with much recent research having revealed previously unrecognized mechanisms by which they contribute to the pathogenesis of infection. Although the pneumococcal capsule has been considered a sine qua non for virulence, the emergence of pathogenic nonencapsulated strains with newly recognized virulence determinants has also been described. Not unexpectedly, but of concern, nonencapsulated strains are unaffected by current pneumococcal vaccines. This, together with the finding of novel virulence factors, as well as new mechanisms of pathogenicity of established virulence determinants, underscores the resilience of the pneumococcus in confronting challenges in its environment, most importantly those posed by antibiotics and vaccines. Recent advances in the understanding of pneumococcal virulence factors provide potential opportunities for the development of nov...Continue Reading

References

Feb 21, 2006·Current Biology : CB·Katharina BeiterBirgitta Henriques-Normark
Jan 16, 2007·Cellular Microbiology·Florian WarthaBirgitta Henriques-Normark
Jun 19, 2015·Clinical Microbiology Reviews·K Aaron GenoMoon H Nahm
Jan 11, 2016·Clinical and Experimental Immunology·J G NelR Anderson
May 20, 2016·Lung·Jan Gert NelGregory R Tintinger
Mar 8, 2017·The Journal of Infection·Jan G NelRonald Anderson
Mar 31, 2018·Nature Reviews. Microbiology·Jeffrey N WeiserJames C Paton
Mar 31, 2018·Frontiers in Microbiology·Sandra M CarvalhoAna R Neves
Apr 12, 2018·International Journal of Molecular Sciences·Ronald AndersonCharles Feldman
Jul 11, 2018·Frontiers in Immunology·Lavida R K Brooks, George I Mias
Aug 21, 2018·International Journal of Biological Macromolecules·Deepthi RadhakrishnanKarthe Ponnuraj
Feb 10, 2019·Microbiology Spectrum·Jing Li, Jing-Ren Zhang
Apr 13, 2019·Microbiology Spectrum·James C Paton, Claudia Trappetti
Aug 30, 2019·PLoS Pathogens·Jessica L Bradshaw, Larry S McDaniel
Sep 5, 2019·Frontiers in Cellular and Infection Microbiology·Masaya YamaguchiShigetada Kawabata
Sep 19, 2019·The Journal of Biological Chemistry·Jessica M GullettCharles O Rock
Sep 26, 2019·Frontiers in Microbiology·Anaïs PelletierSébastien Guiral
Sep 27, 2019·Frontiers in Microbiology·Moses B AyoolaBindu Nanduri
Oct 9, 2019·The Journal of Biological Chemistry·Lukas J TroxlerMarkus Hilty

❮ Previous
Next ❯

Citations

Apr 3, 2021·Frontiers in Cellular and Infection Microbiology·Hisanori Domon, Yutaka Terao
Mar 28, 2021·Journal of Applied Microbiology·P S Lannes-CostaP E Nagao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
D A WatsonJ Verhoef
Future Microbiology
Julie A Preston, David H Dockrell
Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
J C PatonR A Lock
Enfermedades infecciosas y microbiología clínica
María del Mar García-SuárezFrancisco J Méndez
© 2021 Meta ULC. All rights reserved